Every cancer journey is unique. Every report we prepare is personalized using the medical records and laboratory reports you provide. Our Precision Cancer Medicine Research Team organizes your information, prepares research-based educational reports, and helps coordinate access to physician-ordered molecular testing and consultations with licensed healthcare professionals when requested.
We explore peer-reviewed scientific literature relating to your reported cancer type, laboratory-reported molecular findings, biomarkers, molecular pathways, emerging diagnostics, and areas of ongoing precision cancer medicine research. Our goal is to help you better understand today’s rapidly evolving science and support informed discussions with your licensed healthcare team.
If you have any questions, please contact our team anytime.
We organize the medical records and laboratory reports you provide into a structured format that supports the preparation of your personalized educational report and scientific literature summary.
We provide educational information about physician-ordered molecular testing, biomarker testing, comprehensive genomic profiling, next-generation sequencing (NGS), liquid biopsy, cancer genomic testing, and other emerging diagnostic technologies, helping you better understand the purpose of these rapidly evolving areas of precision cancer medicine.
Using your reported cancer type and laboratory-reported molecular findings as the foundation, we prepare a personalized educational report that compiles selected peer-reviewed scientific literature relating to reported biomarkers, molecular pathways, precision cancer medicine, targeted therapies, immunotherapy, emerging diagnostics, and areas of ongoing cancer research.
Our team prepares an educational summary of published scientific literature relating to your reported cancer type and laboratory-reported molecular findings, including research involving cancers with similar molecular characteristics, biomarkers, or molecular pathways. These summaries are intended to support informed discussions with your licensed healthcare team.
When requested, CTOAM helps coordinate consultations with licensed medical oncologists, surgeons, medical geneticists, and other appropriately qualified healthcare professionals. To support these consultations, CTOAM organizes the medical records and laboratory reports you provide and prepares research-based educational reports and scientific literature summaries relating to your reported cancer type, laboratory-reported molecular findings, biomarkers, molecular pathways, molecular testing, comprehensive genomic profiling, liquid biopsy, emerging diagnostics, and current areas of precision cancer medicine research.
These educational materials are intended to help patients and consulting physicians engage in informed discussions about current scientific evidence. All medical opinions, diagnoses, interpretation of laboratory findings, treatment decisions, prescribing, patient monitoring, and ongoing medical management remain the responsibility of the licensed healthcare professional.
Cancer research evolves rapidly. We compile current peer-reviewed scientific literature relating to molecular testing, biomarker discoveries, precision cancer medicine, comprehensive genomic profiling, liquid biopsy, cancer genomics, targeted therapies, immunotherapy, clinical trials, molecular pathways, and emerging diagnostic technologies relevant to the educational topics included in your report.
We compile selected peer-reviewed scientific literature relating to nutrition, lifestyle, supportive care, and complementary approaches that have been investigated in relation to your reported cancer type, laboratory-reported biomarkers, molecular pathways, or other areas of ongoing cancer research. These educational resources are intended for discussion with your licensed healthcare team.
Based on the educational topics included in your report, we prepare a personalized list of research topics and questions that may help guide discussions with your licensed physician, consulting medical oncologist, surgeon, genetic specialist, or other members of your healthcare team regarding molecular testing, biomarkers, emerging diagnostics, clinical trials, and current areas of precision cancer medicine research.
Every package includes curated educational resources covering molecular testing, biomarker testing, cancer genomic testing, precision cancer medicine, liquid biopsy, comprehensive genomic profiling, targeted therapies, immunotherapy, clinical trials, and other rapidly evolving areas of cancer research to help you continue learning beyond your report.
As additional laboratory findings become available over time, CTOAM can prepare updated educational reports that compile current peer-reviewed scientific literature relating to newly reported molecular findings, biomarkers, molecular pathways, and emerging areas of precision cancer medicine research. Where appropriate, these educational reports may incorporate laboratory-generated molecular data, including whole-transcriptome liquid RNA (LRNA) technologies, to help patients and their healthcare teams stay informed about the evolving scientific literature.
Precision cancer medicine continues to evolve. CTOAM helps patients and families stay informed about emerging research, molecular testing technologies, biomarker discoveries, clinical trials, and other developments in precision cancer medicine through ongoing educational resources and research updates.
If you have any questions, please contact us.
"I can’t tell you how much your support means to me. My call today with you was invaluable. You came into our lives at the perfect time. It’s rare to just be able to talk without a sales pitch. I could tell that my needs were more important." - Diane
Explore today’s precision cancer medicine research before making important treatment decisions. Get your questions answered now
Join over 20,000 patients, caregivers and advocates who rely on CTOAM for trusted updates on precision cancer medicine, molecular testing, biomarker discoveries, clinical trials, emerging diagnostics, and research-based educational resources designed to help you navigate today’s rapidly evolving cancer landscape.
Explore today’s precision cancer medicine research before making important treatment decisions.